title: Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?
abstract: We report on a 69-year-old woman who presented with myalgia, hearing impairment, fever, night sweats, weight loss, muscular weakness, paresthesia, hypesthesia, and hypalgesia. Sural nerve biopsy showed demyelinative and axonal polyneuropathy due to necrotizing vasculitis with fibrinoid necrosis. A positive test for antineutrophil cytoplasmic antibodies (ANCA) with a perinuclear immunofluorescence pattern directed against myeloperoxidase was more suggestive of microscopic polyangiitis (MPA) than of polyarteritis nodosa (PAN), the possible differential diagnoses. In addition, positive tests for cytomegalovirus (CMV) antibodies (immunoglobulin (Ig)M and IgG) and the detection of CMV-DNA in sputum specimens by polymerase chain reaction (PCR) were indicative of active CMV infection. Treatment with ganciclovir and anti-CMV immunoglobulin in addition to prednisolone medication for 6 months resulted in rapid improvement of the clinical symptoms without relapse. CMV infection has been described to be related to ANCA-associated vasculitis in non-immunocompromized patients and may be either a causative agent or an opportunistic infection. Identification of a viral etiology in patients with atypical ANCA-associated vasculitides may lead to different, less aggressive treatment approaches, including antiviral therapy.
authors.affiliation: Department of Internal Medicine, University Clinic Bergmannsheil, Bochum, Germany.
authors.forename: M F
authors.initials: MF
authors.lastname: Meyer
authors.forename: B
authors.initials: B
authors.lastname: Hellmich
authors.forename: S
authors.initials: S
authors.lastname: Kotterba
authors.forename: H
authors.initials: H
authors.lastname: Schatz
mesh_terms: D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood; D000914:Antibodies, Viral / Q000008:administration & dosage / Q000097:blood; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D004279:DNA, Viral / Q000032:analysis; D003937:Diagnosis, Differential; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage / Q000097:blood; D009336:Necrosis; D009894:Opportunistic Infections / Q000209:etiology* / Q000473:pathology; D010488:Polyarteritis Nodosa / Q000097:blood / Q000175:diagnosis; D016133:Polymerase Chain Reaction; D014657:Vasculitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D000914:Antibodies, Viral; D004279:DNA, Viral; D007136:Immunoglobulins; D015774:Ganciclovir